PROPRANOLOL
Drugs in Pregnancy and Lactation.
Welcome to Pregnancy Without PoundsYou absolutely DO NOT have to pack on extra pregnancy weight.
Get a FREE subscription to my Pregnancy Exercise, Diet and Beauty Tips Newsletter sent to you each week.Sign In! |
Name: PROPRANOLOL
Class: Sympatholytic (Antihypertensive)
Risk Factor: CM*
Fetal Risk Summary
Propranolol, a nonselective b-adrenergic blocking agent, has been used for various indications in pregnancy:
Maternal hyperthyroidism (1,2,3,4,5,6 and 7)
Pheochromocytoma (8)
Maternal cardiac disease (6,7,9,10,11,12,13,14,15,16,17,18,19 and 20)
Fetal tachycardia or arrhythmia (21,22)
Maternal hypertension (7,20,2324,25,26,27,28,29 and 30)
Dysfunctional labor (31)
Termination of pregnancy (32)
Reproduction studies in rats revealed embryotoxicity (increased resorption sites and reduced litter sizes) and reduced neonatal survival at doses up to about 10 times the maximum recommended human dose (MRHD) (33). No embryotoxicity was observed in rabbits at doses up to about 20 times the MRHD. No teratogenicity was noted in either species.
The drug readily crosses the placenta (2,6,12,16,22,29,34,35). Cord serum levels varying between 19% and 127% of maternal serum have been reported (2,16,22,29). Oxytocic effects have been demonstrated following IV, extra-amniotic injections, and high oral dosing (17,31,32,36,37). IV propranolol has been shown to block or decrease the marked increase in maternal plasma progesterone induced by vasopressin or theophylline (38). The pharmacokinetics of propranolol in pregnancy have been described (39). Plasma levels and elimination were not significantly altered by pregnancy.
A number of fetal and neonatal adverse effects have been reported following the use of propranolol in pregnancy. Whether these effects were caused by propranolol, maternal disease, other drugs consumed concurrently, or a combination of these factors is not always clear. Daily doses of 160 mg or higher seem to produce the more serious complications, but lower doses have also resulted in toxicity. Analysis of 23 reports involving 167 liveborn infants exposed to chronic propranolol in utero is shown below (1,2,3 and 4,6,7,9,11,12,13 and 14,20,22,23 and 24,26,27,28 and 29,40,41,42 and 43):
No. Cases
%
Intrauterine growth retardation
In a surveillance study of Michigan Medicaid recipients involving 229,101 completed pregnancies conducted between 1985 and 1992, 274 newborns had been exposed to propranolol during the 1st trimester (F. Rosa, personal communication, FDA, 1993). A total of 11 (4.0%) major birth defects were observed (12 expected), including (observed/expected) 3/3 cardiovascular defects and 2/1 hypospadias. No anomalies were observed in four other defect categories (oral clefts, spina bifida, polydactyly, and limb reduction defects) for which specific data were available.
Respiratory depression was noted in four of five infants whose mothers were given 1 mg of propranolol IV just before cesarean section (45). None of the five controls in the double-blind study was depressed at birth. The author suggested the mechanism may have been b-adrenergic blockade of the cervical sympathetic discharge that occurs at cord clamping.
Fetal bradycardia was observed in 2 of 10 patients treated with propranolol, 1 mg/minute for 4 minutes, for dysfunctional labor (31). No lasting effects were seen in the babies. In a retrospective study, 8 markedly hypertensive patients (9 pregnancies) treated with propranolol were compared with 15 hypertensive controls not treated with propranolol (25). Other antihypertensives were used in both groups. A significant difference was found between the perinatal mortality rates, with 7 deaths in the propranolol group (78%) and only 5 deaths in the controls (33%). However, a possible explanation for the difference may have been the more severe hypertension and renal disease in the propranolol group than in the controls (46).
Intrauterine growth retardation may be related to propranolol. Several possible mechanisms for this effect, if indeed it is associated with the drug, have been reviewed (47). Premature labor has been suggested as a possible complication of propranolol therapy in patients with pregnancy-induced hypertension (PIH) (42). In nine women treated with propranolol for PIH, three delivered prematurely. The author speculated that these patients were relatively hypovolemic and when a compensatory increase in cardiac output failed to occur, premature delivery resulted. However, another report on chronic propranolol use in 14 women did not observe premature labor (43).
In a randomized, double-blind trial, 36 patients at term were given either 80 mg of propranolol or placebo (48). Fetal heart rate reaction to a controlled sound stimulus was then measured at 1, 2, and 3 hours. The heart rate reaction in the propranolol group was significantly depressed, compared with placebo, at all three time intervals.
The reactivity of nonstress tests (NSTs) was affected by propranolol in two hypertensive women in the 2nd and 3rd trimesters (49). One woman was taking 20 mg every 6 hours and the other 10 mg 3 times daily. Repeated NSTs were nonreactive in both women, but immediate follow-up contraction stress tests were negative. The NSTs became reactive 2 and 10 days, respectively, after propranolol was discontinued.
In summary, propranolol has been used during pregnancy for maternal and fetal indications. The drug is apparently not a teratogen, but fetal and neonatal toxicity may occur. A 1988 review on the use of b-blockers, including propranolol, during pregnancy concluded that these agents are relatively safe (50), but some b-blockers, including propranolol, may cause intrauterine growth retardation and reduced placental weight (e.g., see also Atenolol). Treatment beginning early in the 2nd trimester results in the greatest weight reductions. This toxicity has not been consistently demonstrated in other agents within this class, but the relatively few pharmacologic differences among the drugs suggests that the reduction in fetal and placental weights probably occurs with all at some point. The lack of toxicity documentation may reflect the number and type of patients studied, the duration of therapy, or the dosage used, rather then a true difference among b-blockers. Although growth retardation is a serious concern, the benefits of maternal therapy with b-blockers may, in some cases, outweigh the risks to the fetus and must be judged on a case-by-case basis.
Newborn infants of women consuming the drug near delivery should be closely observed during the first 2448 hours after birth for bradycardia, hypoglycemia, and other symptoms of b-blockade. Long-term effects of in utero exposure to b-blockers have not been studied but warrant evaluation.
[*Risk Factor D if used in 2nd or 3rd trimesters.]
Breast Feeding Summary
Propranolol is excreted into breast milk. Peak concentrations occur 23 hours after a dose (12,20,43,51). Milk levels have ranged from 4 to 64 ng/mL, with milk:plasma ratios of 0.21.5 (12,20,29,50). Although such adverse effects as respiratory depression, bradycardia, and hypoglycemia have not been reported, nursing infants exposed to propranolol in breast milk should be closely observed for these symptoms of b-blockade. Long-term effects of exposure to b-blockers from milk have not been studied but warrant evaluation. The American Academy of Pediatrics considers propranolol to be compatible with breast feeding (52).
References
- Jackson GL. Treatment of hyperthyroidism in pregnancy. Pa Med 1973;76:567.
- Langer A, Hung CT, McA'Nulty JA, Harrigan JT, Washington E. Adrenergic blockade: a new approach to hyperthyroidism during pregnancy. Obstet Gynecol 1974;44:1816.
- Bullock JL, Harris RE, Young R. Treatment of thyrotoxicosis during pregnancy with propranolol. Am J Obstet Gynecol 1975;121:2425.
- Lightner ES, Allen HD, Loughlin G. Neonatal hyperthyroidism and heart failure: a different approach. Am J Dis Child 1977;131:6870.
- Levy CA, Waite JH, Dickey R. Thyrotoxicosis and pregnancy. Use of preoperative propranolol for thyroidectomy. Am J Surg 1977;133:31921.
- Habib A, McCarthy JS. Effects on the neonate of propranolol administered during pregnancy. J Pediatr 1977;91:80811.
- Pruyn SC, Phelan JP, Buchanan GC. Long-term propranolol therapy in pregnancy: maternal and fetal outcome. Am J Obstet Gynecol 1979;135:4859.
- Leak D, Carroll JJ, Robinson DC, Ashworth EJ. Management of pheochromocytoma during pregnancy. Can Med Assoc J 1977;116:3715.
- Turner GM, Oakley CM, Dixon HG. Management of pregnancy complicated by hypertrophic obstructive cardiomyopathy. Br Med J 1968;4:2814.
- Barnes AB. Chronic propranolol administration during pregnancy: a case report. J Reprod Med 1970;5:7980.
- Schroeder JS, Harrison DC. Repeated cardioversion during pregnancy. Am J Cardiol 1971;27:4456.
- Levitan AA, Manion JC. Propranolol therapy during pregnancy and lactation. Am J Cardiol 1973;32:247.
- Reed RL, Cheney CB, Fearon RE, Hook R, Hehre FW. Propranolol therapy throughout pregnancy: a case report. Anesth Analg (Cleve) 1974;53:2148.
- Fiddler GI. Propranolol pregnancy. Lancet 1974;2:7223.
- Kolibash AE, Ruiz DE, Lewis RP. Idiopathic hypertrophic subaortic stenosis in pregnancy. Ann Intern Med 1975;82:7914.
- Cottrill CM, McAllister RG Jr, Gettes L, Noonan JA. Propranolol therapy during pregnancy, labor, and delivery: Evidence for transplacental drug transfer and impaired neonatal drug disposition. J Pediatr 1977;91:8124.
- Datta S, Kitzmiller JL, Ostheimer GW, Schoenbaum SC. Propranolol and parturition. Obstet Gynecol 1978;51:57781.
- Diaz JH, McDonald JS. Propranolol and induced labor: Anesthetic implications. Anesth Rev 1979;6:2932.
- Oakley GDG, McGarry K, Limb DG, Oakley CM. Management of pregnancy in patients with hypertrophic cardiomyopathy. Br Med J 1979;1:174950.
- Bauer JH, Pape B, Zajicek J, Groshong T. Propranolol in human plasma and breast milk. Am J Cardiol 1979;43:8602.
- Eibschitz I, Abinader EG, Klein A, Sharf M. Intrauterine diagnosis and control of fetal ventricular arrhythmia during labor. Am J Obstet Gynecol 1975;122:597600.
- Teuscher A, Boss E, Imhof P, Erb E, Stocker FP, Weber JW. Effect of propranolol on fetal tachycardia in diabetic pregnancy. Am J Cardiol 1978;42:3047.
- Gladstone GR, Hordof A, Gersony WM. Propranolol administration during pregnancy: Effects on the fetus. J Pediatr 1975;86:9624.
- Tcherdakoff PH, Colliard M, Berrard E, Kreft C, Dupry A, Bernaille JM. Propranolol in hypertension during pregnancy. Br Med J 1978;2:670.
- Lieberman BA, Stirrat GM, Cohen SL, Beard RW, Pinker GD, Belsey E. The possible adverse effect of propranolol on the fetus in pregnancies complicated by severe hypertension. Br J Obstet Gynaecol 1978;85:67883.
- Eliahou HE, Silverberg DS, Reisin E, Romen I, Mashiach S, Serr DM. Propranolol for the treatment of hypertension in pregnancy. Br J Obstet Gynaecol 1978;85:4316.
- Bott-Kanner G, Schweitzer A, Schoenfeld A, Joel-Cohen J, Rosenfeld JB. Treatment with propranolol and hydralazine throughout pregnancy in a hypertensive patient: a case report. Isr J Med Sci 1978;14:4668.
- Bott-Kanner G, Reisner SH, Rosenfeld JB. Propranolol and hydralazine in the management of essential hypertension in pregnancy. Br Obstet Gynaecol 1980;87:1104.
- Taylor EA, Turner P. Anti-hypertensive therapy with propranolol during pregnancy and lactation. Postgrad Med J 1981;57:42730.
- Serup J. Propranolol for the treatment of hypertension in pregnancy. Acta Med Scand 1979;206:333.
- Mitrani A, Oettinger M, Abinader EG, Sharf M, Klein A. Use of propranolol in dysfunctional labour. Br J Obstet Gynaecol 1975;82:6515.
- Amy JJ, Karim SMM. Intrauterine administration of 1-noradrenaline and propranolol during the second trimester of pregnancy. J Obstet Gynaecol Br Commonw 1974;81:7583.
- Product information. Inderal. Wyeth-Ayerst Laboratories, 1997.
- Smith MT, Livingstone I, Eadie MJ, Hooper WD, Triggs EJ. Metabolism of propranolol in the human maternal-placental-foetal unit. Eur J Clin Pharmacol 1983;24:72732.
- Erkkola R, Lammintausta R, Liukko P, Anttila M. Transfer of propranolol and sotalol across the human placenta. Acta Obstet Gynecol Scand 1982;61:314.
- Barden TP, Stander RW. Myometrial and cardiovascular effects of an adrenergic blocking drug in human pregnancy. Am J Obstet Gynecol 1968;101:919.
- Wansbrough H, Nakanishi H, Wood C. The effect of adrenergic receptor blocking drugs on the human fetus. J Obstet Gynaecol Br Commonw 1968;75:18998.
- Fylling P. Dexamethasone or propranolol blockade of induced increase in plasma progesterone in early human pregnancy. Acta Endocrinol (Copenh) 1973;72:56972.
- Smith MT, Livingstone I, Eadie MJ, Hooper WD, Triggs EJ. Chronic propranolol administration during pregnancy: maternal pharmacokinetics. Eur J Clin Pharmacol 1983;25:48190.
- O'Connor PC, Jick H, Hunter JR, Stergachis A, Madsen S. Propranolol and pregnancy outcome. Lancet 1981;2:1168.
- Caldroney RD. Beta-blockers in pregnancy. N Engl J Med 1982;306:810.
- Goodlin RC. Beta blocker in pregnancy-induced hypertension. Am J Obstet Gynecol 1982;143:237.
- Livingstone I, Craswell PW, Bevan EB, Smith MT, Eadie MJ. Propranolol in pregnancy: three year prospective study. Clin Exp Hypertens (B) 1983;2:34150.
- Duminy PC, Burger P du T. Fetal abnormality associated with the use of captopril during pregnancy. S Afr Med J 1981;60:805.
- Tunstall ME. The effect of propranolol on the onset of breathing at birth. Br J Anaesth 1969;41:792.
- Rubin PC. Beta-blockers in pregnancy. N Engl J Med 1981;305:13236.
- Redmond GP. Propranolol and fetal growth retardation. Semin Perinatol 1982;6:1427.
- Jensen OH. Fetal heart rate response to a controlled sound stimulus after propranolol administration to the mother. Acta Obstet Gynecol Scand 1984;63:199202.
- Margulis E, Binder D, Cohen AW. The effect of propranolol on the nonstress test. Am J Obstet Gynecol 1984;148:3401.
- Frishman WH, Chesner M. Beta-adrenergic blockers in pregnancy. Am Heart J 1988;115:14752.
- Karlberg B, Lundberg O, Aberg H. Excretion of propranolol in human breast milk. Acta Pharmacol Toxicol (Copenh) 1974;34:2224.
- Committee on Drugs, American Academy of Pediatrics. The transfer of drugs and other chemicals into human milk. Pediatrics 1994;93:13750.
Q&A about Propranolol
Suppose a person has propranolol before severe exercise, how will it change his endurance to exercise ?
Propranolol will impair the body's ability to increase the heart rate. If an individual is unable to increase stroke volume, the heart may not be able to meet the demands that exercise is putting on it, impairing endurance.
(SAMI, there certainly ARE false positive stress tests, as evidenced by nuclear imaging. Symptoms do not always mean ischemia, which is why the nuclear portion of the test is done.)_
I know this may not get many answers. But I have started taking propranolol hoping it will help my rosacea and I will be taking 10 mg a day which isnt much for someone 170 lbs. Still, I am a little nervous it seems like a powerful drug. I will probably discontinue it soon because I have taken it previously and once it made me feel a little weird while engaging in moderate exercise. Maybe it also robs me some of my personality, I cant quite tell.
just don't worry about it.
i take stimulants and mood stabilizers, i thought it'd make me a zombie but it didnt. both adderal and lamictal are strong drugs too....ttrust me, they wouldn't put it on the market if it could kill you.
every drug is different. just because it's 10mg doesn't mean anything. i take 20mg adderal vs. what i used to on ritalin which was i dont know higher in mg rating.
it's fine
just take it.
I plan on drinking tonight, but first I will be going to a dinner which will be a social situation (difficult for me) and am wondering if it will be OK to take the propranolol before the dinner considering that I will be drinking later that night. I would probably only take 10 mg. Thanks for any advice!
do you REALLY think drinking ALCOHOL while on a beta blocker will NOT be DANGEROUS at all????
THINK.
it doesn't matter if you skip one pill it is still in your system.
prescription medication should NOT be going into the same body alcohol is going into.
Is it possible to kill yourself by overdosing on propranolol?
How many would it take?
Too many would kill you.
If you suspect overdose, contact the emergency department ASAP
My doctor gave me some propranolol pills for stage fright and he said i should just let it dissolve on my tongue but it tastes so nasty that i cant couldnt handle it. Any suggestions?
I've been on Propranolol for migraines for over a month now and I'm having some signs that I might be pregnant. I'm on Yasmin for birth control, plus my partner and I use other forms of protection. I was just wondering if this new medication could have made the Yasmin not work (like anti-biotics do).
http://www.rxlist.com/script/main/hp.asp
it is the Internet drug index for prescription drugs and medications...
I'm taking propranolol for anxiety for a few years but have been experiencing palpitations lately. I dont want to increase my doseage but I have heard that taking aloe vera tablets reduces palpitations. Does anyone know if they are ok to take together? Thanks.
Hi, about to start taking 10mg of propranolol three times daily, but im already using 100mg sertraline and occassionally diazepam, could there be any adverse side effects?? If anyone has any first hand experience this would be much appreciated, im apprehensive of how this will effect me during working hours!
Generic name: Propranolol hydrochloride
If Inderal is taken with certain other drugs, the effects of either could be increased, decreased, or altered. It is especially important to check with your doctor before combining Inderal with the following:
Alcohol
Aluminum hydroxide gel
Antipyrine
Calcium-blocking blood pressure drugs such as diltiazem, nifedipine, and verapamil
Certain high blood pressure medications such as reserpine
Chlorpromazine
Cimetidine
Epinephrine
Haloperidol
Insulin
Lidocaine
Nonsteroidal anti-inflammatory drugs such as ibuprofen and naproxen
Oral diabetes drugs such as glyburide
Phenobarbitone
Phenytoin
Rifampin
Theophylline
Thyroid medications such as levothyroxine
The doctor prescribed me the beta blocker Propranolol to control the symptoms of my social anxiety- blushing, sweating, stammering etc, they are working like a miracle at just 10mg per day.
I'm just curious about how in lay-mans terms, they work so well?
What other conditions is the drug used to treat?
There are 2 main types of Beta Blocker, those that block 1 or 2 or work to block both.
Stimulation of Ξ²1 receptors by epinephrine (this is one of the main stress hormones). It induces a positive forceful effect on the heart. Blocking it reduces the amount released.
Stimulation of Ξ²2 receptors on the kidney causes renin release. This results in vasodilation (enlarging blood vessels) and bronchodilation (opening up the airways). It also induces tremor in skeletal muscle, and increases glycogenolysis (making energy for you). Blocking this is what stops the blushing and tremor.
Beta Blockers block these actions from happening.
Propranalol is a non-selective (works at both B1 and B2) used mainly used in the treatment of hypertension.
Some others are more selective working only on the Beta 1 receptors (so they effect the heart but not the lungs). This is good if you have asthma as you don't want to stop your lungs opening up. With anxiety though you don't need more oxygen as you are already probably overbreathing.
Hi hoping someone can help me. Ive just been given Propranolol 10mg from the docs for anxiety. I used to take Half Inderal LA 80 and ive found that it is made from propranolol too. Can anyone tell me the difference between these two tablets and which is "stronger"?? Ta very much x

